Genomic profiling, biomarkers, liquid biopsy, AI-driven diagnostics, molecular pathology, hereditary cancer syndromes.
Now in its sixth edition, ICPOC 2026 brings together the brightest minds in oncology to discuss cutting-edge research, emerging therapies, and precision medicine breakthroughs. Our mission is to bridge the gap between laboratory discovery and clinical application — translating scientific advances into tangible improvements in patient outcomes worldwide. Over three intensive days, delegates will engage with plenary lectures, hands-on workshops, abstract presentations, and curated networking events designed to spark cross-disciplinary collaboration.
This year's hybrid format ensures that clinicians and scientists unable to attend in person can still participate fully through our interactive virtual platform. Virtual delegates enjoy live-streamed sessions, on-demand content for 90 days post-event, and dedicated online networking tools. Whether you join us in Singapore or online, you will have access to the same world-class scientific programme and the same opportunities to connect with leading experts in the field.
What makes ICPOC unique is its unwavering commitment to precision oncology as a unifying theme. Rather than treating cancer as a single disease, our programme embraces the molecular, genetic, and environmental diversity of cancer — exploring how personalised approaches are reshaping prevention, diagnosis, treatment, and survivorship. With 15 CME credits, publication opportunities in our partner journal, and a faculty drawn from the world's top institutions, ICPOC 2026 is an unmissable event for anyone committed to the future of cancer care.
To advance global cancer care by fostering collaboration among oncologists, researchers, and industry leaders.
To be the world's leading forum for precision oncology — a place where the next generation of cancer treatments is debated, refined, and born.
To be the world's leading forum for precision oncology — a place where the next generation of cancer treatments is debated, refined, and born.